No Data
10 Health Care Stocks Whale Activity In Today's Session
Returns On Capital At Cigna Group (NYSE:CI) Have Hit The Brakes
Morgan Stanley Maintains Cigna Group(CI.US) With Buy Rating, Maintains Target Price $403
Wells Fargo Maintains Cigna Group(CI.US) With Hold Rating, Maintains Target Price $355
The cigna group clarifies that it will not seek to merge with Humana in the future and will actively repurchase stocks.
Gelonghui November 12th | The Cigna Group stated on Monday that it will not seek to merge with its competitor Humana, and is still focused on an acquisition that is 'strategically consistent, financially attractive, and likely to be completed'. Earlier reports suggested that Cigna had restarted plans to merge with Humana, with both parties having terminated acquisition negotiations last year due to failure to reach a price agreement. Cigna also stated that it is expected to actively repurchase stocks in the fourth quarter and in 2025, and will announce this news before meeting with investors and analysts in the coming weeks. Analysts point out that after the U.S. presidential election, Humana's stock price rose as investors bet on President Trump.
Dow Ends Session on Top While S&P and Nasdaq Inch up With CPI Data Looming